10-K/A: American Vanguard Files 10-K/A Amendment to Correct Auditor Consent Dates and Clarify Proxy Statement Incorporation

Sentiment:

Amendment to Annual Report


American Vanguard Corporation has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to correct incorrect dates in its independent auditor's consent and to clarify the incorporation of information from its proxy statement.

Summary

  • American Vanguard Corporation (the Company) filed Amendment No. 1 on Form 10-K/A to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
  • The primary purpose of this amendment is to provide an amended Consent of Deloitte & Touche LLP, the Company's Independent Registered Public Accounting Firm, to correct incorrect dates included in the original Consent.
  • Additionally, the amendment clarifies the cover page of the Original Form 10-K to state that no information is being incorporated into Part III of the Annual Report from the Company's definitive proxy statement relating to its 2025 annual meeting of stockholders, with all such information included directly in the Annual Report.
  • This Amendment No. 1 explicitly states that no other changes have been made to the Original Form 10-K, and it does not modify, amend, or update any financial or other disclosures presented in the Original Form 10-K.
  • The amendment does not reflect events that may have occurred subsequent to the Original Filing Date of May 29, 2025.
  • New certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 are attached, with paragraphs 3, 4, and 5 omitted due to the absence of financial statements or amendments to Items 307 and 308 of Regulation S-K.
  • Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 have also been omitted as no financial statements are included in this amendment.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a technical amendment for compliance purposes, correcting minor administrative errors without impacting financial results or strategic direction.

Positives

  • The filing demonstrates the Company's commitment to regulatory compliance by correcting administrative errors in a timely manner.
  • The clarification regarding the incorporation of Part III information enhances transparency and ensures all required disclosures are directly accessible within the Annual Report.

Negatives

  • The necessity of filing an amendment to correct dates in an auditor's consent indicates a minor administrative oversight in the initial filing.

Risks

  • This amendment does not introduce new risks or update existing risk factors; it explicitly states that it does not modify financial or other disclosures from the original 10-K.

Future Outlook

This Amendment No. 1 does not contain any new forward-looking statements or guidance, as it explicitly states that it does not reflect events that may have occurred subsequent to the original filing date of the Form 10-K.

Management Comments

  • Douglas A. Kaye III, Chief Executive Officer and Chairman of the Board, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading.
  • David T. Johnson, Chief Financial Officer and Principal Accounting Officer, provided a similar certification regarding the accuracy and completeness of the report.
  • The Company stated that the amendment was filed to correct incorrect dates in the auditor's consent and to clarify the incorporation of information from the proxy statement, with no other changes to the original financial or other disclosures.

Industry Context

This filing is a routine administrative amendment and does not provide new information related to broader industry trends, competitive landscape, or the company's position within the agricultural chemicals or crop protection industry.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerEric G. Wintemute (referenced in exhibits as having a Transition Agreement dated July 3, 2024, and Cooperation Agreement dated April 15, 2025)Douglas A. Kaye III (referenced in exhibits as having an Executive Employment Agreement dated December 9, 2024, and signed as CEO in this filing)Not explicitly stated as effective date in this document, but agreements referenced are from July and December 2024.Not detailed in this amendment, but implied by transition and employment agreements referenced.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Information Incorporation ClarificationThe cover page of the Original Form 10-K was amended to clarify that no information is being incorporated into Part III from the Company's definitive proxy statement, with all such information included directly in the Annual Report.May 30, 2025 (filing date of amendment)Enhances transparency and ensures all required corporate governance disclosures are self-contained within the Annual Report, simplifying access for stakeholders.

Stakeholder Impact

  • Shareholders: Provides clarity on the accuracy of auditor consent dates and the location of corporate governance information, ensuring compliance and ease of access to disclosures.
  • Regulatory Authorities: Demonstrates adherence to SEC filing requirements and responsiveness in correcting administrative errors.

Next Steps

  • The Company has completed the necessary corrections for its Annual Report on Form 10-K through this amendment.

Key Dates

DateDescription
2024-06-30Estimated date for aggregate market value of voting stock held by non-affiliates ($240.6 million) and common stock outstanding (34,655,429 shares).
2024-12-31Fiscal year ended for the Annual Report on Form 10-K.
2025-03-05Date for common stock outstanding (28,266,826 shares).
2025-05-28Date of Deloitte & Touche LLP's report and consent.
2025-05-29Original Annual Report on Form 10-K filed with the SEC.
2025-05-30Filing date of Amendment No. 1 on Form 10-K/A and date of CEO/CFO certifications.

Keywords

American Vanguard Corporation, AVD, SEC Filing, 10-K/A, Amendment, Annual Report, Auditor Consent, Financial Reporting, Corporate Governance, SEC Compliance, Public Accounting Firm, Sarbanes-Oxley Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.